Photo from wikipedia
Newer generation drug-eluting stents (DES) may allow for early discontinuation of dual antiplatelet therapy (DAPT). DAPT duration after PCI has not been validated in cancer patients. We aimed to describe… Click to show full abstract
Newer generation drug-eluting stents (DES) may allow for early discontinuation of dual antiplatelet therapy (DAPT). DAPT duration after PCI has not been validated in cancer patients. We aimed to describe the practices and outcomes regarding DAPT duration in a cancer population with DES. We
Keywords:
drug eluting;
newer generation;
eluting stents;
generation drug;
cancer;
dual antiplatelet
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!